Cargando…
Noninferior Antibiotics: When Is “Not Bad” “Good Enough”?
Novel treatment options are urgently needed for patients with serious multidrug-resistant infections seen increasingly in routine everyday clinical practice, both in the hospital and nursing home as well as in the clinic and office setting. Unfortunately, the problem is no longer confined to chronic...
Autor principal: | DiNubile, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929489/ https://www.ncbi.nlm.nih.gov/pubmed/27382597 http://dx.doi.org/10.1093/ofid/ofw110 |
Ejemplares similares
-
Good enough practices in scientific computing
por: Wilson, Greg, et al.
Publicado: (2017) -
When enough data are not enough to enact policy: The failure to ban chlorpyrifos
por: Trasande, Leonardo
Publicado: (2017) -
The good, the bad, the ugly - PPE and the COVID-19 pandemic
por: Proffitt, Edmund
Publicado: (2022) -
Intermittent Hypoxia and Respiratory Plasticity: The Good, the Bad, and the Unknown
por: Sheel, Andrew William
Publicado: (2023) -
COVID-19 and global equity for health: The good, the bad, and the wicked
por: Geng, Elvin H., et al.
Publicado: (2021)